Hi Everyone,

The Spring, 2009, issue of "Momentum," the official quarterly publication of the
American National MS Society, contains an article about Low Dose Naltrexone
written by noted MS specialist, Dr. Allen C. Bowling.

The article cites several studies bearing on the safety and efficacy of LDN in
the treatment of MS.

It concludes with the statement that

"larger and more rigorous studies are needed to get definitive answers to
important and still unanswered questions:

Does LDN truly decrease the severity of MS symptoms?

Does LDN slow down relapsing or progressive MS?

Is LDN safe to use over the long term?

Does LDN interact with conventional MS medications?"

Personally, I found the article quite disappointing, because it seems to be
written with the express purpose of discouraging MSers from trying LDN

For example, there is no mention of the insignificant cost and minimal side
effects of LDN in comparison to "conventional MS medications." And there is no
mention of the scads of personal testimonies in which disease progress is halted
and/or symptoms lessened.

As far as interactions are concerned, only Copaxone is deemed compatible with
LDN, and, in terms of long-term safety, LDN has been in use since the
mid-1980's, with no adverse reports existent (that I am aware of) regarding
safety issues.

The article refers MSers to this website for more information about LDN:

http://www.nationalMSsociety.org/LDN

I visited that site but, for some reason, got a blank page. Perhaps it will
display for you.

In my opinion, a much better source of information about LDN is this site:

http://tinyurl.com/intro-to-ldn

With best wishes,

Dudley Delany, R.N., M.A., D.C.

http://profiles.yahoo.com/dudley_delany



[Non-text portions of this message have been removed]